The global market for Drug-eluting Coronary Stents was valued at US$ 1916 million in the year 2024 and is projected to reach a revised size of US$ 2545 million by 2031, growing at a CAGR of 4.2% during the forecast period.

Drug-eluting Coronary Stents Market

Drug-eluting Coronary Stents which is coated with medication that reduces the risk of the artery becoming blocked again

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Drug-eluting Coronary Stents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug-eluting Coronary Stents.

The Drug-eluting Coronary Stents market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug-eluting Coronary Stents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Drug-eluting Coronary Stents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Drug-eluting Coronary Stents Market Report

Report Metric	Details
Report Name	Drug-eluting Coronary Stents Market
Accounted market size in year	US$ 1916 million
Forecasted market size in 2031	US$ 2545 million
CAGR	4.2%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Stent Diameter ＜4mm Stent Diameter ＞4mm
Segment by Application	ASCs Hospitals Cardiology Center Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Medtronic, Boston Scientific, Biosensors, Terumo, MicroPort, Lepu Medical, B.Braun, Atrium Medical, SINOMED, LBC, Essen Technology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Drug-eluting Coronary Stents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Drug-eluting Coronary Stents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Drug-eluting Coronary Stents Market growing?

Ans: The Drug-eluting Coronary Stents Market witnessing a CAGR of 4.2% during the forecast period 2025-2031.

What is the Drug-eluting Coronary Stents Market size in 2031?

Ans: The Drug-eluting Coronary Stents Market size in 2031 will be US$ 2545 million.

Who are the main players in the Drug-eluting Coronary Stents Market report?

Ans: The main players in the Drug-eluting Coronary Stents Market are Medtronic, Boston Scientific, Biosensors, Terumo, MicroPort, Lepu Medical, B.Braun, Atrium Medical, SINOMED, LBC, Essen Technology

What are the Application segmentation covered in the Drug-eluting Coronary Stents Market report?

Ans: The Applications covered in the Drug-eluting Coronary Stents Market report are ASCs, Hospitals, Cardiology Center, Others

What are the Type segmentation covered in the Drug-eluting Coronary Stents Market report?

Ans: The Types covered in the Drug-eluting Coronary Stents Market report are Stent Diameter ＜4mm, Stent Diameter ＞4mm

1 Drug-eluting Coronary Stents Market Overview

1.1 Product Definition

1.2 Drug-eluting Coronary Stents by Type

1.2.1 Global Drug-eluting Coronary Stents Market Value Comparison by Type (2024 VS 2031)

1.2.2 Stent Diameter ＜4mm

1.2.3 Stent Diameter ＞4mm

1.3 Drug-eluting Coronary Stents by Application

1.3.1 Global Drug-eluting Coronary Stents Market Value by Application (2024 VS 2031)

1.3.2 ASCs

1.3.3 Hospitals

1.3.4 Cardiology Center

1.3.5 Others

1.4 Global Drug-eluting Coronary Stents Market Size Estimates and Forecasts

1.4.1 Global Drug-eluting Coronary Stents Revenue 2020-2031

1.4.2 Global Drug-eluting Coronary Stents Sales 2020-2031

1.4.3 Global Drug-eluting Coronary Stents Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Drug-eluting Coronary Stents Market Competition by Manufacturers

2.1 Global Drug-eluting Coronary Stents Sales Market Share by Manufacturers (2020-2025)

2.2 Global Drug-eluting Coronary Stents Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Drug-eluting Coronary Stents Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Drug-eluting Coronary Stents, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Drug-eluting Coronary Stents, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Drug-eluting Coronary Stents, Product Type & Application

2.7 Global Key Manufacturers of Drug-eluting Coronary Stents, Date of Enter into This Industry

2.8 Global Drug-eluting Coronary Stents Market Competitive Situation and Trends

2.8.1 Global Drug-eluting Coronary Stents Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Drug-eluting Coronary Stents Players Market Share by Revenue

2.8.3 Global Drug-eluting Coronary Stents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Drug-eluting Coronary Stents Market Scenario by Region

3.1 Global Drug-eluting Coronary Stents Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Drug-eluting Coronary Stents Sales by Region: 2020-2031

3.2.1 Global Drug-eluting Coronary Stents Sales by Region: 2020-2025

3.2.2 Global Drug-eluting Coronary Stents Sales by Region: 2026-2031

3.3 Global Drug-eluting Coronary Stents Revenue by Region: 2020-2031

3.3.1 Global Drug-eluting Coronary Stents Revenue by Region: 2020-2025

3.3.2 Global Drug-eluting Coronary Stents Revenue by Region: 2026-2031

3.4 North America Drug-eluting Coronary Stents Market Facts & Figures by Country

3.4.1 North America Drug-eluting Coronary Stents Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Drug-eluting Coronary Stents Sales by Country (2020-2031)

3.4.3 North America Drug-eluting Coronary Stents Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Drug-eluting Coronary Stents Market Facts & Figures by Country

3.5.1 Europe Drug-eluting Coronary Stents Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Drug-eluting Coronary Stents Sales by Country (2020-2031)

3.5.3 Europe Drug-eluting Coronary Stents Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Drug-eluting Coronary Stents Market Facts & Figures by Region

3.6.1 Asia Pacific Drug-eluting Coronary Stents Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Drug-eluting Coronary Stents Sales by Region (2020-2031)

3.6.3 Asia Pacific Drug-eluting Coronary Stents Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Drug-eluting Coronary Stents Market Facts & Figures by Country

3.7.1 Latin America Drug-eluting Coronary Stents Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Drug-eluting Coronary Stents Sales by Country (2020-2031)

3.7.3 Latin America Drug-eluting Coronary Stents Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Drug-eluting Coronary Stents Market Facts & Figures by Country

3.8.1 Middle East and Africa Drug-eluting Coronary Stents Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Drug-eluting Coronary Stents Sales by Country (2020-2031)

3.8.3 Middle East and Africa Drug-eluting Coronary Stents Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Drug-eluting Coronary Stents Sales by Type (2020-2031)

4.1.1 Global Drug-eluting Coronary Stents Sales by Type (2020-2025)

4.1.2 Global Drug-eluting Coronary Stents Sales by Type (2026-2031)

4.1.3 Global Drug-eluting Coronary Stents Sales Market Share by Type (2020-2031)

4.2 Global Drug-eluting Coronary Stents Revenue by Type (2020-2031)

4.2.1 Global Drug-eluting Coronary Stents Revenue by Type (2020-2025)

4.2.2 Global Drug-eluting Coronary Stents Revenue by Type (2026-2031)

4.2.3 Global Drug-eluting Coronary Stents Revenue Market Share by Type (2020-2031)

4.3 Global Drug-eluting Coronary Stents Price by Type (2020-2031)

5 Segment by Application

5.1 Global Drug-eluting Coronary Stents Sales by Application (2020-2031)

5.1.1 Global Drug-eluting Coronary Stents Sales by Application (2020-2025)

5.1.2 Global Drug-eluting Coronary Stents Sales by Application (2026-2031)

5.1.3 Global Drug-eluting Coronary Stents Sales Market Share by Application (2020-2031)

5.2 Global Drug-eluting Coronary Stents Revenue by Application (2020-2031)

5.2.1 Global Drug-eluting Coronary Stents Revenue by Application (2020-2025)

5.2.2 Global Drug-eluting Coronary Stents Revenue by Application (2026-2031)

5.2.3 Global Drug-eluting Coronary Stents Revenue Market Share by Application (2020-2031)

5.3 Global Drug-eluting Coronary Stents Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Medtronic

6.1.1 Medtronic Company Information

6.1.2 Medtronic Description and Business Overview

6.1.3 Medtronic Drug-eluting Coronary Stents Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Medtronic Drug-eluting Coronary Stents Product Portfolio

6.1.5 Medtronic Recent Developments/Updates

6.2 Boston Scientific

6.2.1 Boston Scientific Company Information

6.2.2 Boston Scientific Description and Business Overview

6.2.3 Boston Scientific Drug-eluting Coronary Stents Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Boston Scientific Drug-eluting Coronary Stents Product Portfolio

6.2.5 Boston Scientific Recent Developments/Updates

6.3 Biosensors

6.3.1 Biosensors Company Information

6.3.2 Biosensors Description and Business Overview

6.3.3 Biosensors Drug-eluting Coronary Stents Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Biosensors Drug-eluting Coronary Stents Product Portfolio

6.3.5 Biosensors Recent Developments/Updates

6.4 Terumo

6.4.1 Terumo Company Information

6.4.2 Terumo Description and Business Overview

6.4.3 Terumo Drug-eluting Coronary Stents Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Terumo Drug-eluting Coronary Stents Product Portfolio

6.4.5 Terumo Recent Developments/Updates

6.5 MicroPort

6.5.1 MicroPort Company Information

6.5.2 MicroPort Description and Business Overview

6.5.3 MicroPort Drug-eluting Coronary Stents Sales, Revenue and Gross Margin (2020-2025)

6.5.4 MicroPort Drug-eluting Coronary Stents Product Portfolio

6.5.5 MicroPort Recent Developments/Updates

6.6 Lepu Medical

6.6.1 Lepu Medical Company Information

6.6.2 Lepu Medical Description and Business Overview

6.6.3 Lepu Medical Drug-eluting Coronary Stents Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Lepu Medical Drug-eluting Coronary Stents Product Portfolio

6.6.5 Lepu Medical Recent Developments/Updates

6.7 B.Braun

6.7.1 B.Braun Company Information

6.7.2 B.Braun Description and Business Overview

6.7.3 B.Braun Drug-eluting Coronary Stents Sales, Revenue and Gross Margin (2020-2025)

6.7.4 B.Braun Drug-eluting Coronary Stents Product Portfolio

6.7.5 B.Braun Recent Developments/Updates

6.8 Atrium Medical

6.8.1 Atrium Medical Company Information

6.8.2 Atrium Medical Description and Business Overview

6.8.3 Atrium Medical Drug-eluting Coronary Stents Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Atrium Medical Drug-eluting Coronary Stents Product Portfolio

6.8.5 Atrium Medical Recent Developments/Updates

6.9 SINOMED

6.9.1 SINOMED Company Information

6.9.2 SINOMED Description and Business Overview

6.9.3 SINOMED Drug-eluting Coronary Stents Sales, Revenue and Gross Margin (2020-2025)

6.9.4 SINOMED Drug-eluting Coronary Stents Product Portfolio

6.9.5 SINOMED Recent Developments/Updates

6.10 LBC

6.10.1 LBC Company Information

6.10.2 LBC Description and Business Overview

6.10.3 LBC Drug-eluting Coronary Stents Sales, Revenue and Gross Margin (2020-2025)

6.10.4 LBC Drug-eluting Coronary Stents Product Portfolio

6.10.5 LBC Recent Developments/Updates

6.11 Essen Technology

6.11.1 Essen Technology Company Information

6.11.2 Essen Technology Description and Business Overview

6.11.3 Essen Technology Drug-eluting Coronary Stents Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Essen Technology Drug-eluting Coronary Stents Product Portfolio

6.11.5 Essen Technology Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Drug-eluting Coronary Stents Industry Chain Analysis

7.2 Drug-eluting Coronary Stents Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Drug-eluting Coronary Stents Production Mode & Process Analysis

7.4 Drug-eluting Coronary Stents Sales and Marketing

7.4.1 Drug-eluting Coronary Stents Sales Channels

7.4.2 Drug-eluting Coronary Stents Distributors

7.5 Drug-eluting Coronary Stents Customer Analysis

8 Drug-eluting Coronary Stents Market Dynamics

8.1 Drug-eluting Coronary Stents Industry Trends

8.2 Drug-eluting Coronary Stents Market Drivers

8.3 Drug-eluting Coronary Stents Market Challenges

8.4 Drug-eluting Coronary Stents Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Drug-eluting Coronary Stents Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Drug-eluting Coronary Stents Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Drug-eluting Coronary Stents Market Competitive Situation by Manufacturers in 2024

Table 4. Global Drug-eluting Coronary Stents Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Drug-eluting Coronary Stents Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Drug-eluting Coronary Stents Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Drug-eluting Coronary Stents Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Drug-eluting Coronary Stents Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Drug-eluting Coronary Stents, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Drug-eluting Coronary Stents, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Drug-eluting Coronary Stents, Product Type & Application

Table 12. Global Key Manufacturers of Drug-eluting Coronary Stents, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Drug-eluting Coronary Stents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug-eluting Coronary Stents as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Drug-eluting Coronary Stents Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Drug-eluting Coronary Stents Sales by Region (2020-2025) & (K Units)

Table 18. Global Drug-eluting Coronary Stents Sales Market Share by Region (2020-2025)

Table 19. Global Drug-eluting Coronary Stents Sales by Region (2026-2031) & (K Units)

Table 20. Global Drug-eluting Coronary Stents Sales Market Share by Region (2026-2031)

Table 21. Global Drug-eluting Coronary Stents Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Drug-eluting Coronary Stents Revenue Market Share by Region (2020-2025)

Table 23. Global Drug-eluting Coronary Stents Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Drug-eluting Coronary Stents Revenue Market Share by Region (2026-2031)

Table 25. North America Drug-eluting Coronary Stents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Drug-eluting Coronary Stents Sales by Country (2020-2025) & (K Units)

Table 27. North America Drug-eluting Coronary Stents Sales by Country (2026-2031) & (K Units)

Table 28. North America Drug-eluting Coronary Stents Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Drug-eluting Coronary Stents Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Drug-eluting Coronary Stents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Drug-eluting Coronary Stents Sales by Country (2020-2025) & (K Units)

Table 32. Europe Drug-eluting Coronary Stents Sales by Country (2026-2031) & (K Units)

Table 33. Europe Drug-eluting Coronary Stents Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Drug-eluting Coronary Stents Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Drug-eluting Coronary Stents Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Drug-eluting Coronary Stents Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Drug-eluting Coronary Stents Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Drug-eluting Coronary Stents Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Drug-eluting Coronary Stents Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Drug-eluting Coronary Stents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Drug-eluting Coronary Stents Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Drug-eluting Coronary Stents Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Drug-eluting Coronary Stents Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Drug-eluting Coronary Stents Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Drug-eluting Coronary Stents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Drug-eluting Coronary Stents Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Drug-eluting Coronary Stents Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Drug-eluting Coronary Stents Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Drug-eluting Coronary Stents Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Drug-eluting Coronary Stents Sales (K Units) by Type (2020-2025)

Table 51. Global Drug-eluting Coronary Stents Sales (K Units) by Type (2026-2031)

Table 52. Global Drug-eluting Coronary Stents Sales Market Share by Type (2020-2025)

Table 53. Global Drug-eluting Coronary Stents Sales Market Share by Type (2026-2031)

Table 54. Global Drug-eluting Coronary Stents Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Drug-eluting Coronary Stents Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Drug-eluting Coronary Stents Revenue Market Share by Type (2020-2025)

Table 57. Global Drug-eluting Coronary Stents Revenue Market Share by Type (2026-2031)

Table 58. Global Drug-eluting Coronary Stents Price (US$/Unit) by Type (2020-2025)

Table 59. Global Drug-eluting Coronary Stents Price (US$/Unit) by Type (2026-2031)

Table 60. Global Drug-eluting Coronary Stents Sales (K Units) by Application (2020-2025)

Table 61. Global Drug-eluting Coronary Stents Sales (K Units) by Application (2026-2031)

Table 62. Global Drug-eluting Coronary Stents Sales Market Share by Application (2020-2025)

Table 63. Global Drug-eluting Coronary Stents Sales Market Share by Application (2026-2031)

Table 64. Global Drug-eluting Coronary Stents Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Drug-eluting Coronary Stents Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Drug-eluting Coronary Stents Revenue Market Share by Application (2020-2025)

Table 67. Global Drug-eluting Coronary Stents Revenue Market Share by Application (2026-2031)

Table 68. Global Drug-eluting Coronary Stents Price (US$/Unit) by Application (2020-2025)

Table 69. Global Drug-eluting Coronary Stents Price (US$/Unit) by Application (2026-2031)

Table 70. Medtronic Company Information

Table 71. Medtronic Description and Business Overview

Table 72. Medtronic Drug-eluting Coronary Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Medtronic Drug-eluting Coronary Stents Product

Table 74. Medtronic Recent Developments/Updates

Table 75. Boston Scientific Company Information

Table 76. Boston Scientific Description and Business Overview

Table 77. Boston Scientific Drug-eluting Coronary Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Boston Scientific Drug-eluting Coronary Stents Product

Table 79. Boston Scientific Recent Developments/Updates

Table 80. Biosensors Company Information

Table 81. Biosensors Description and Business Overview

Table 82. Biosensors Drug-eluting Coronary Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Biosensors Drug-eluting Coronary Stents Product

Table 84. Biosensors Recent Developments/Updates

Table 85. Terumo Company Information

Table 86. Terumo Description and Business Overview

Table 87. Terumo Drug-eluting Coronary Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Terumo Drug-eluting Coronary Stents Product

Table 89. Terumo Recent Developments/Updates

Table 90. MicroPort Company Information

Table 91. MicroPort Description and Business Overview

Table 92. MicroPort Drug-eluting Coronary Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. MicroPort Drug-eluting Coronary Stents Product

Table 94. MicroPort Recent Developments/Updates

Table 95. Lepu Medical Company Information

Table 96. Lepu Medical Description and Business Overview

Table 97. Lepu Medical Drug-eluting Coronary Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Lepu Medical Drug-eluting Coronary Stents Product

Table 99. Lepu Medical Recent Developments/Updates

Table 100. B.Braun Company Information

Table 101. B.Braun Description and Business Overview

Table 102. B.Braun Drug-eluting Coronary Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. B.Braun Drug-eluting Coronary Stents Product

Table 104. B.Braun Recent Developments/Updates

Table 105. Atrium Medical Company Information

Table 106. Atrium Medical Description and Business Overview

Table 107. Atrium Medical Drug-eluting Coronary Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Atrium Medical Drug-eluting Coronary Stents Product

Table 109. Atrium Medical Recent Developments/Updates

Table 110. SINOMED Company Information

Table 111. SINOMED Description and Business Overview

Table 112. SINOMED Drug-eluting Coronary Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. SINOMED Drug-eluting Coronary Stents Product

Table 114. SINOMED Recent Developments/Updates

Table 115. LBC Company Information

Table 116. LBC Description and Business Overview

Table 117. LBC Drug-eluting Coronary Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. LBC Drug-eluting Coronary Stents Product

Table 119. LBC Recent Developments/Updates

Table 120. Essen Technology Company Information

Table 121. Essen Technology Description and Business Overview

Table 122. Essen Technology Drug-eluting Coronary Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Essen Technology Drug-eluting Coronary Stents Product

Table 124. Essen Technology Recent Developments/Updates

Table 125. Key Raw Materials Lists

Table 126. Raw Materials Key Suppliers Lists

Table 127. Drug-eluting Coronary Stents Distributors List

Table 128. Drug-eluting Coronary Stents Customers List

Table 129. Drug-eluting Coronary Stents Market Trends

Table 130. Drug-eluting Coronary Stents Market Drivers

Table 131. Drug-eluting Coronary Stents Market Challenges

Table 132. Drug-eluting Coronary Stents Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

Table 136. Authors List of This Report

List of Figures

Figure 1. Product Picture of Drug-eluting Coronary Stents

Figure 2. Global Drug-eluting Coronary Stents Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Drug-eluting Coronary Stents Market Share by Type: 2024 & 2031

Figure 4. Stent Diameter ＜4mm Product Picture

Figure 5. Stent Diameter ＞4mm Product Picture

Figure 6. Global Drug-eluting Coronary Stents Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Drug-eluting Coronary Stents Market Share by Application: 2024 & 2031

Figure 8. ASCs

Figure 9. Hospitals

Figure 10. Cardiology Center

Figure 11. Others

Figure 12. Global Drug-eluting Coronary Stents Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Drug-eluting Coronary Stents Market Size (2020-2031) & (US$ Million)

Figure 14. Global Drug-eluting Coronary Stents Sales (2020-2031) & (K Units)

Figure 15. Global Drug-eluting Coronary Stents Average Price (US$/Unit) & (2020-2031)

Figure 16. Drug-eluting Coronary Stents Report Years Considered

Figure 17. Drug-eluting Coronary Stents Sales Share by Manufacturers in 2024

Figure 18. Global Drug-eluting Coronary Stents Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Drug-eluting Coronary Stents Players: Market Share by Revenue in Drug-eluting Coronary Stents in 2024

Figure 20. Drug-eluting Coronary Stents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Drug-eluting Coronary Stents Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Drug-eluting Coronary Stents Sales Market Share by Country (2020-2031)

Figure 23. North America Drug-eluting Coronary Stents Revenue Market Share by Country (2020-2031)

Figure 24. United States Drug-eluting Coronary Stents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Drug-eluting Coronary Stents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Drug-eluting Coronary Stents Sales Market Share by Country (2020-2031)

Figure 27. Europe Drug-eluting Coronary Stents Revenue Market Share by Country (2020-2031)

Figure 28. Germany Drug-eluting Coronary Stents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Drug-eluting Coronary Stents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Drug-eluting Coronary Stents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Drug-eluting Coronary Stents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Drug-eluting Coronary Stents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Drug-eluting Coronary Stents Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Drug-eluting Coronary Stents Revenue Market Share by Region (2020-2031)

Figure 35. China Drug-eluting Coronary Stents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Drug-eluting Coronary Stents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Drug-eluting Coronary Stents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Drug-eluting Coronary Stents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Drug-eluting Coronary Stents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Drug-eluting Coronary Stents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Drug-eluting Coronary Stents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Latin America Drug-eluting Coronary Stents Sales Market Share by Country (2020-2031)

Figure 43. Latin America Drug-eluting Coronary Stents Revenue Market Share by Country (2020-2031)

Figure 44. Mexico Drug-eluting Coronary Stents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Brazil Drug-eluting Coronary Stents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Argentina Drug-eluting Coronary Stents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Middle East and Africa Drug-eluting Coronary Stents Sales Market Share by Country (2020-2031)

Figure 48. Middle East and Africa Drug-eluting Coronary Stents Revenue Market Share by Country (2020-2031)

Figure 49. Turkey Drug-eluting Coronary Stents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Drug-eluting Coronary Stents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. UAE Drug-eluting Coronary Stents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Global Sales Market Share of Drug-eluting Coronary Stents by Type (2020-2031)

Figure 53. Global Revenue Market Share of Drug-eluting Coronary Stents by Type (2020-2031)

Figure 54. Global Drug-eluting Coronary Stents Price (US$/Unit) by Type (2020-2031)

Figure 55. Global Sales Market Share of Drug-eluting Coronary Stents by Application (2020-2031)

Figure 56. Global Revenue Market Share of Drug-eluting Coronary Stents by Application (2020-2031)

Figure 57. Global Drug-eluting Coronary Stents Price (US$/Unit) by Application (2020-2031)

Figure 58. Drug-eluting Coronary Stents Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-37W13091

Thu Feb 20 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Intracardiac Echocardiography (ICE) Catheter Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-16J13119

Thu Feb 20 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Angiography Tubing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-1D10536

Tue Feb 18 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Dialysis Fluid Filter Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-0B10817

Tue Feb 18 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Drug-eluting Coronary Stents Market Research Report 2025

Published Date: February 2025

Report Code: QYRE-Auto-13I12449

Global Drug-eluting Coronary Stents Market Research Report 2025

FEATURED COMPANIES

Drug-eluting Coronary Stents Market Size

Drug-eluting Coronary Stents Market

Report Scope

Scope of Drug-eluting Coronary Stents Market Report

Core Chapters

FAQ for this report

How fast is Drug-eluting Coronary Stents Market growing?

What is the Drug-eluting Coronary Stents Market size in 2031?

Who are the main players in the Drug-eluting Coronary Stents Market report?

What are the Application segmentation covered in the Drug-eluting Coronary Stents Market report?

What are the Type segmentation covered in the Drug-eluting Coronary Stents Market report?

FEATURED COMPANIES

RELATED REPORTS

$5800

Enterprise User

$5800

Enterprise User

$5800

Enterprise User

$5800

Enterprise User